Novartis Will Stand Tough On Sales Force Size, CEO Costa Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Potential cuts to competitors' sales forces will give Novartis an opportunity to "leverage that asset," the exec says. Novartis' sales force continues to offer a strong return on investment, he notes.